Fulvestrant Alone Versus Fulvestrant and Everolimus Versus Fulvestrant, Everolimus and Anastrozole: A Phase III Randomized Placebo-Controlled Trial in Postmenopausal Patients
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Anastrozole (Primary) ; Everolimus (Primary) ; Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 20 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 11 Dec 2014 Trial design presented at the 37th Annual San Antonio Breast Cancer Symposium.